Myriad Genetics, GSK Partner to Expand Access to HRD Diagnostic Testing-April 2024-www.financetom.com

Myriad Genetics, GSK Partner to Expand Access to HRD Diagnostic Testing

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Myriad Genetics, GSK Partner to Expand Access to HRD Diagnostic Testing

Jun 11, 2024 6:33 AM

09:04 AM EDT, 06/11/2024 (MT Newswires) -- Myriad Genetics ( MYGN ) said Tuesday it has partnered with GSK (GSK) to support access to homologous recombination deficiency diagnostic testing for patients with high-grade serous ovarian cancer.

A sponsored testing plan utilizing Myriad's MyChoice HRD Plus and MyChoice CDx Plus Tests is now available in Argentina, Brazil, Chile, Colombia, Egypt, Netherlands, Saudi Arabia, Singapore, and the United Arab Emirates, the company said.

Previous page： Greenpro Capital Unit to Sign MoU With Sharia Digital Technologies Dubai, Digital Syariah Teknologi Surabaya Next page： McKesson to buy controlling stake in Florida Cancer Specialists' unit for about $2.5 billion

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Greenpro Capital Unit to Sign MoU With Sharia Digital Technologies Dubai, Digital Syariah Teknologi Surabaya

Aug 26, 2024

11:12 AM EDT, 08/26/2024 (MT Newswires) -- Greenpro Capital's ( GRNQ ) subsidiary GreenX said Monday it will sign memorandum of understanding with Sharia Digital Technologies FZ LLC - Dubai and PT Digital Syariah Teknologi Surabaya on Tuesday. The MOU represents a key step toward expanding the reach of GreenX's global platform and bringing Shariah-compliant digital assets to Islamic communities,...

McKesson to buy controlling stake in Florida Cancer Specialists' unit for about $2.5 billion

Aug 26, 2024

(Reuters) -Drug distributor McKesson said on Monday it would buy a controlling stake in community cancer center Florida Cancer Specialists & Research Institute's (FCS) business and administrative services unit for $2.49 billion in cash. McKesson would own roughly a 70% stake in the unit, Core Ventures, which manages non-clinical administrative functions such as providing operational and advisory support services to...

Libya's eastern government says all oilfields to close

Aug 26, 2024

* No confirmation from recognised government or NOC * Waha Oil says plans to reduce output gradually * No orders to reduce output yet, two sources tell Reuters * Tensions over central bank, bank says suspending operations * Force majeure declared at Sharara earlier citing protests (Adds central bank temporarily halting services, paragraphs 11-14) By Ayman Werfali BENGHAZI, Aug 26...

United States Lime & Minerals Insider Sold Shares Worth $934,560, According to a Recent SEC Filing

Aug 26, 2024

11:11 AM EDT, 08/26/2024 (MT Newswires) -- Richard W Cardin, Director, on August 22, 2024, sold 12,000 shares in United States Lime & Minerals ( USLM ) for $934,560. Following the Form 4 filing with the SEC, Cardin has control over a total of 14,300 shares of the company, with 14,300 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/82020/000120497524000015/xslF345X05/primary_doc.xml Price: 82.31, Change:...